Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trialDiwakar Davar, Janis M. Taube, Robert M. Morrison et al.|Cancer Cell|2024Cited by 60
Phase IB study of pembrolizumab (Pembro) and pegylated-interferon alfa-2b (Peg-IFN) in advanced melanoma (MEL).Diwakar Davar, Giuseppe Lo Russo, Ornella Pagliano et al.|Journal of Clinical Oncology|2016Cited by 2